Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT) - PubMed (original) (raw)
Clinical Trial
Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT)
Edgar R Miller 3rd et al. Hypertension. 2002 Nov.
Abstract
National guidelines for the prevention and treatment of hypertension recommend sodium reduction, weight loss, the Dietary Approach to Stop Hypertension (DASH) diet, and regular aerobic exercise. However, no trial has assessed the efficacy of simultaneously implementing all of these recommendations. The objective of this study was to determine the effects on blood pressure and other cardiovascular disease risk factors of a comprehensive lifestyle intervention. We conducted a randomized controlled trial of 44 hypertensive, overweight adults on a single blood pressure medication. Participants were randomized to a lifestyle or control group. For 9 weeks, the lifestyle group was fed a hypocaloric version of the DASH diet that provided 100 mmol/d of sodium. This group also participated in a supervised, moderate-intensity exercise program 3 times per week. The control group received no intervention. Outcomes were ambulatory blood pressure, serum lipids, weight, and fitness. At the end of the intervention, mean weight loss in the lifestyle group, net of control, was 4.9 kilograms. In the lifestyle group mean net reductions in 24-hour ambulatory systolic and diastolic blood pressures were 9.5 mm Hg (P<0.001) and 5.3 mm Hg (P<0.002), respectively. Corresponding changes in daytime systolic and diastolic blood pressures were 12.1 mm Hg (P<0.001) and 6.6 mm Hg (P<0.001). The lifestyle group experienced mean reductions in total cholesterol (-25 mg/dL, P<0.001), low-density lipoprotein cholesterol (-18 mg/dL, P=0.005), high-density lipoprotein cholesterol (-5 mg/dL, P<0.001), net of control. In conclusion, among hypertensive overweight adults already on antihypertensive medication, a comprehensive lifestyle intervention can substantially lower blood pressure and improve blood pressure control.
Similar articles
- Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR; Writing Group of the PREMIER Collaborative Research Group. Appel LJ, et al. JAMA. 2003 Apr 23-30;289(16):2083-93. doi: 10.1001/jama.289.16.2083. JAMA. 2003. PMID: 12709466 Clinical Trial. - Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.
Fuchs FD, Gus M, Moreira WD, Moreira LB, Moraes RS, Rosito GA, Sorucco A, Atanázio P, Machado R. Fuchs FD, et al. J Hypertens. 1997 Jul;15(7):783-92. doi: 10.1097/00004872-199715070-00011. J Hypertens. 1997. PMID: 9222947 - Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Patnode CD, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. PMID: 29364620 Free Books & Documents. Review. - Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Lin JS, O'Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Lin JS, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. Report No.: 13-05179-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. Report No.: 13-05179-EF-1. PMID: 25232633 Free Books & Documents. Review.
Cited by
- A qualitative analysis of perceptions and barriers to therapeutic lifestyle changes among homeless hypertensive patients.
Moczygemba LR, Kennedy AK, Marks SA, Goode JV, Matzke GR. Moczygemba LR, et al. Res Social Adm Pharm. 2013 Jul-Aug;9(4):467-81. doi: 10.1016/j.sapharm.2012.05.007. Epub 2012 Jul 25. Res Social Adm Pharm. 2013. PMID: 22835705 Free PMC article. - Treatment of the metabolic syndrome: the impact of lifestyle modification.
Pritchett AM, Foreyt JP, Mann DL. Pritchett AM, et al. Curr Atheroscler Rep. 2005 Mar;7(2):95-102. doi: 10.1007/s11883-005-0030-4. Curr Atheroscler Rep. 2005. PMID: 15727723 Review. - Emerging global epidemic of obesity: the renal perspective.
Saxena AK. Saxena AK. Ann Saudi Med. 2006 Jul-Aug;26(4):288-95. doi: 10.5144/0256-4947.2006.288. Ann Saudi Med. 2006. PMID: 16883080 Free PMC article. Review. - The interplay of obesity and asthma.
Plumb J, Brawer R, Brisbon N. Plumb J, et al. Curr Allergy Asthma Rep. 2007 Sep;7(5):385-9. doi: 10.1007/s11882-007-0058-3. Curr Allergy Asthma Rep. 2007. PMID: 17697648 Review. - Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months.
Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW, Subak LL; Program to Reduce Incontinence by Diet and Exercise Group. Wing RR, et al. J Urol. 2010 Sep;184(3):1005-10. doi: 10.1016/j.juro.2010.05.031. J Urol. 2010. PMID: 20643425 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical